Finance

Lists
ZYDUSLIFE:NSE
Zydus Lifesciences Ltd
၁,၁၁၉.၃၀ ₹
-၀.၃၃%
(-၃.၇၀) 1D
အောက် ၁၉, GMT+၅:၃၀ ၁၁:၄၉:၃၈  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ZYDUSLIFE...
Open
၁,၁၁၆.၄၀ ₹
High
၁,၁၃၄.၂၀ ₹
Low
၁,၁၁၆.၄၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သိန်း
Avg. vol.
၁.၅၀ သန်း
Volume
၁.၄၅ သိန်း
Dividend
၀.၀၉%
Quarterly dividend
၀.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၂၄.၉၅
52-wk high
၁,၂၃၂.၁၀ ₹
52-wk low
၈၃၅.၅၀ ₹
EPS
၄၄.၈၇ ₹
No. of employees
၃ သောင်း
Open
၁,၁၁၆.၄၀ ₹
High
၁,၁၃၄.၂၀ ₹
Low
၁,၁၁၆.၄၀ ₹
Mkt. cap
ဋေ ၁.၁၂ သိန်း
Avg. vol.
၁.၅၀ သန်း
Volume
၁.၄၅ သိန်း
Dividend
၀.၀၉%
Quarterly dividend
၀.၂၅ ₹
Ex-dividend date
၂၀၂၆ ဇူ ၂၄
P/E ratio
၂၄.၉၅
52-wk high
၁,၂၃၂.၁၀ ₹
52-wk low
၈၃၅.၅၀ ₹
EPS
၄၄.၈၇ ₹
No. of employees
၃ သောင်း
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
Poland's Medicalgorithmics Signs LOI For Potential $67 Mln Takeover By US Nasdaq-Listed Firm
Kalkine Media
Kalkine Media
·
ပြီးခဲ့သည့် ၃၇ မိနစ်
Why is Enphase Energy (NASDAQ:ENPH) back in the spotlight today?
MarketBeat
MarketBeat
·
ပြီးခဲ့သည့် ၄၄ မိနစ်
1stdibs.com (NASDAQ:DIBS) Stock Rating Cut to Hold at Wall Street Zen
Bloomberg.com
Bloomberg.com
·
ပြီးခဲ့သည့် ၈ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad. Primarily engaged in the manufacturing of generic drugs, the company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
About Zydus Lifesciences Ltd
CEO-
Employees၃ သောင်း
Founded၁၉၅၂
Headquarters-
Sector-
Last report
၂၀၂၆ ဩ ၁၁
Fiscal period
Q1 2027
၉.၄၈ ₹ / ၁၁.၁၅ ₹
-၁၄.၉၈%miss
Revenue / Est. (INR)
ဋေ ၈.၀၂ ထ / ဋေ ၇.၆၉ ထ
+၄.၃၀%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၆.၁၂ ထ
ဋေ ၆.၈၆ ထ
ဋေ ၇.၅၉ ထ
ဋေ ၈.၀၂ ထ
Cost of goods sold
ဋေ ၁.၆၉ ထ
ဋေ ၁.၈၄ ထ
ဋေ ၂.၂၁ ထ
ဋေ ၂.၂၄ ထ
Cost of revenue
ဋေ ၁.၆၉ ထ
ဋေ ၁.၈၄ ထ
ဋေ ၂.၂၁ ထ
ဋေ ၂.၂၄ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၀၃ ထ
ဋေ ၁.၁၄ ထ
ဋေ ၃.၂၉ ထ
ဋေ ၁.၃၇ ထ
Operating expense
ဋေ ၃.၁၃ ထ
ဋေ ၃.၇၄ ထ
ဋေ ၃.၉၄ ထ
ဋေ ၄.၄၆ ထ
Total operating expenses
ဋေ ၄.၈၂ ထ
ဋေ ၅.၅၇ ထ
ဋေ ၆.၁၅ ထ
ဋေ ၆.၇၀ ထ
Operating income
ဋေ ၁.၃၀ ထ
ဋေ ၁.၂၉ ထ
ဋေ ၁.၄၄ ထ
ဋေ ၁.၃၂ ထ
Other non operating income
၁၀၉.၀၀ ဋေ
၁၁၁.၄၀ ဋေ
-၃၇၀.၂၀ ဋေ
၁၀၆.၁၀ ဋေ
EBT including unusual items
ဋေ ၁.၆၉ ထ
ဋေ ၁.၄၁ ထ
ဋေ ၁.၆၆ ထ
ဋေ ၁.၃၄ ထ
EBT excluding unusual items
ဋေ ၁.၇၃ ထ
ဋေ ၁.၅၀ ထ
ဋေ ၂.၀၉ ထ
ဋေ ၁.၃၆ ထ
Income tax expense
၄၅၄.၀၀ ဋေ
၃၈၈.၃၀ ဋေ
၃၁၈.၄၀ ဋေ
၃၅၄.၂၀ ဋေ
Effective tax rate
၂၆.၈၂%
၂၇.၅၂%
၁၉.၁၉%
၂၆.၃၅%
Other operating expenses
ဋေ ၁.၈၀ ထ
ဋေ ၂.၂၄ ထ
၁၂၇.၉၀ ဋေ
ဋေ ၂.၅၄ ထ
Net income
ဋေ ၁.၂၆ ထ
ဋေ ၁.၀၄ ထ
ဋေ ၁.၂၇ ထ
၉၃၉.၈၀ ဋေ
Net profit margin
၂၀.၅၅%
၁၅.၁၈%
၁၆.၇၇%
၁၁.၇၂%
Earnings per share
၁၂.၇၆
၁၀.၉၆
၁၅.၈၄
၉.၄၈
Interest and investment income
-
-
၄၂၃.၇၀ ဋေ
-
Interest expense
-၁၀၁.၃၀ ဋေ
-၁၂၉.၉၀ ဋေ
-၄၉.၁၀ ကုဋေ
-၁၅၆.၀၀ ဋေ
Net interest expenses
-၁၀၁.၃၀ ဋေ
-၁၂၉.၉၀ ဋေ
၃၇၄.၆၀ ဋေ
-၁၅၆.၀၀ ဋေ
Depreciation and amortization charges
၃၀၁.၉၀ ဋေ
၃၅၉.၆၀ ဋေ
၅၀၈.၄၀ ဋေ
၅၅၄.၇၀ ဋေ
EBITDA
ဋေ ၁.၅၇ ထ
ဋေ ၁.၅၁ ထ
ဋေ ၁.၇၇ ထ
ဋေ ၁.၆၅ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ